|
1
|
Kyle RA and Rajkumar SV: Multiple myeloma.
Blood. 111:2962–2972. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kyle RA: Diagnostic criteria of multiple
myeloma. Hematol Oncol Clin North Am. 6:347–358. 1992.PubMed/NCBI
|
|
3
|
Boccadoro M and Pileri A: Diagnosis,
prognosis, and standard treatment of multiple myeloma. Hematol
Oncol Clin North Am. 11:111–131. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeGramont A, Grosbois B, Michaux JL, Peny
AM, Pollet JP, Smadja N, Krulik M, Debray J, Bernard JF and
Monconduit M: IgM myeloma: 6 cases and a review of the literature.
Rev Med Interne. 11:13–18. 1990.(In French). PubMed/NCBI
|
|
5
|
Dierlamm T, Laack E, Dierlamm J, Fiedler W
and Hossfeld DK: IgM myeloma: A report of four cases. Ann Hematol.
81:136–139. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dimopoulos MA, Panayiotidis P, Moulopoulos
LA, Sfikakis P and Dalakas M: Waldenström's macroglobulinemia:
Clinical features, complications, and management. J Clin Oncol.
18:214–226. 2000.PubMed/NCBI
|
|
7
|
Schuster SR, Rajkumar SV, Dispenzieri A,
Morice W, Aspitia AM, Ansell S, Kyle R and Mikhael J: IgM multiple
myeloma: Disease definition, prognosis, and differentiation from
Waldenstrom's macroglobulinemia. Am J Hematol. 85:853–855. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dimopoulos M, Terpos E, Comenzo RL, Tosi
P, Beksac M, Sezer O, Siegel D, Lokhorst H, Kumar S, Rajkumar SV,
et al: IMWG: International myeloma working group consensus
statement and guidelines regarding the current role of imaging
techniques in the diagnosis and monitoring of multiple myeloma.
Leukemia. 23:1545–1556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Annibali O, Petrucci MT, Del Bianco P,
Gallucci C, Levi A, Foà R and Avvisati G: IgM multiple myeloma:
Report of four cases and review of the literature. Leuk Lymphoma.
47:1565–1569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haghighi B, Yanagihara R and Cornbleet PJ:
IgM myeloma: Case report with immunophenotypic profile. Am J
Hematol. 59:302–308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Avet-Loiseau H, Garand R, Lodé L,
Harousseau JL and Bataille R: Intergroupe Francophone du Myélome:
Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and
nonsecretory multiple myeloma variants. Blood. 101:1570–1571. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y,
Liu X, Morra E, Trojani A, Greco A, Arcaini L, et al: MYD88 L265P
in Waldenström macroglobulinemia, immunoglobulin M monoclonal
gammopathy, and other B-cell lymphoproliferative disorders using
conventional and quantitative allele-specific polymerase chain
reaction. Blood. 121:2051–2058. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morris C, Drake M, Apperley J, Iacobelli
S, van Biezen A, Bjorkstrand B, Goldschmidt H, Harousseau JL,
Morgan G, de Witte T, et al: Myeloma Subcommittee of Chronic
Leukaemia Working Party of EBMT: Efficacy and outcome of autologous
transplantation in rare myelomas. Haematologica. 95:2126–2133.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moreau P, San Miguel J, Ludwig H, Schouten
H, Mohty M, Dimopoulos M and Dreyling M: ESMO Guidelines Working
Group: Multiple myeloma: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 24(Suppl 6):
vi133–vi137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kyle RA, Therneau TM, Rajkumar SV,
Remstein ED, Offord JR, Larson DR, Plevak MF and Melton LJ III:
Long-term follow-up of IgM monoclonal gammopathy of undetermined
significance. Blood. 102:3759–3764. 2003. View Article : Google Scholar : PubMed/NCBI
|
